ORGANOGENESIS INC.

In News

Organogenesis: High-Tech Skin Substitute Company On Sale (NASDAQ:ORGO) - Seeking Alpha

Seeking Alpha - Dec 11, 2025

Organogenesis Provides Update on Second Phase 3 ReNu® Study - Ortho Spine News

Ortho Spine News - Sep 26, 2025

Organogenesis Holdings Leads The Charge With 2 Other Promising Penny Stocks - Yahoo Finance

Yahoo Finance - Jun 20, 2025

Organogenesis Holdings Inc reports results for the quarter ended September 30 - Earnings Summary - TradingView — Track All Markets

TradingView — Track All Markets - Nov 06, 2025

Organogenesis Holdings Inc. Announced Results from Second Phase 3 Trial of ReNu for Knee Osteoarthritis Pain Management - Quiver Quantitative

Quiver Quantitative - Sep 25, 2025

Organogenesis Expands Footprint with Full-Building Lease at Davis Biomanufacturing Facility in Smithfield, RI - Boston Real Estate Times

Boston Real Estate Times - May 15, 2025

Organogenesis Holdings Inc.'s (NASDAQ:ORGO) Shares Bounce 27% But Its Business Still Trails The Industry - simplywall.st

simplywall.st - Nov 27, 2025

Organogenesis Holdings: Stock Riding Market Waves? - StocksToTrade

StocksToTrade - Nov 07, 2025

Earnings call transcript: Organogenesis Q1 2025 sees revenue drop, stock plummets - Investing.com

Investing.com - May 08, 2025

Organogenesis (NASDAQ: ORGO) raises guidance to $500–$525M after record revenue - Stock Titan

Stock Titan - Nov 06, 2025

Organogenesis Inks Full-Building Lease with Davis in RI - Connect CRE

Connect CRE - May 19, 2025

Organogenesis Holdings Inc. (NASDAQ:ORGO) Q2 2025 Earnings Call Transcript - Insider Monkey

Insider Monkey - Aug 12, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment